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Residual B Cell Function and Insulin Sensitivity in Type I (Insulin-Dependent) Diabetes Mellitus
Sir, It is now well established that many Type 1 diabetic subjects continue to have some degree of residual B cell function [1] . The metabolic importance of this endogenous insulin production has been emphasized recently in Diabetologia [2] . However, the mechanism(s) whereby persistent B cell secretion may facilitate good metabolic control is poorly understood. Thus, it is of interest that we found a significant positive relationship between basal B cell secretion rate and insulin sensitivity in Type i diabetic patients with detectable fasting C-peptide [3] .
In the present study, we measured insulin sensitivity in two groups of 12 Type i diabetic subjects that differed with respect to residual B cell function. Twelve patients had evidence of residual B cell function, with fasting C-peptide>0.40ng/ml (0.13 nmol/1), assessed by the method of Kaneko et al. [4] . The other 12 individuals had undetectable C-peptide, both fasting and in response to IV glucagon. The two groups were similar in sex, age, body weight and plasma glucose concentration. No subject had a serum binding affinity for 125I-Insulin > 10% [5] .
The subjects stopped their regular insulin for 12 h and their longacting insulin for 48 h before the study. After an overnight fast, at 08.00 h they received a bolus IV injection of regular insulin (Actrapid MC, Novo, 0.1 IU/kg body weight). Blood samples were taken from an antecubital vein through an indwelling cannula kept patent by a slow 0.9% saline infusion before and 5,10,15, 20, 25, 30, 35, 40 min after the insulin injection. The glucose disappearance rate with time was calculated from 5 to 25 rain after the insulin injection, and used as an index of insulin sensitivity as described by Alford et al. [6] and BeckNielsen et al. [7] .
The diabetic subjects with residual B cell function showed significantly higher coefficients of insulin sensitivity than those without endogenous insulin secretion ( Table 1) .
The difference in insulin sensitivity may explain, at least in part, the lower insulin requirement and better metabolic control in those Type 1 diabetic subjects with residual B cell activity [2] . Indeed, a continued secretion of insulin into the portal vein and hence directly into the liver may be very important in controlling the hepatic abnormalities of diabetes [8, 9] . In particular, persistent endogenous insulin production might help to suppress hepatic glucose production and to promote glucose uptake and disposal by the liver, muscle, and adipose tissue.
Yours sincerely, E. Bonora, C. Coscelli and U. Butturini
